Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (251-260 of 367) with videos related to

Pageof 37
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2021
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1Louise Cadman, Caroline Reuter, Mark Jitlal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyRichard Buus, Ivana Sestak, Stephen Barron, et al.
Vaccine|December 4, 2012
New technologies and procedures for cervical cancer screeningJack Cuzick, Christine Bergeron, Magnus von Knebel Doeberitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2008
Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smearsAnne Szarewski, Laurence Ambroisine, Louise Cadman, et al.
BJU International|November 6, 2007
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and gradingDaniel M Berney, Gabrielle Fisher, Michael W Kattan, et al.
Breast Cancer Research : BCR|September 30, 2020
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 yearsAdam R Brentnall, Ruth Warren, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|April 29, 2015
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trialPatricia A Mote, Anne Gompel, Chris Howe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention TrialsJack Cuzick, Adam R Brentnall, Corrinne Segal, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
Urologic Oncology|April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillanceDaniel W Lin, E David Crawford, Thomas Keane, et al.
Pageof 37

Showing results (251-260 of 367) with videos related to

Sort By:
Pageof 37
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 30, 2021
A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1Louise Cadman, Caroline Reuter, Mark Jitlal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyRichard Buus, Ivana Sestak, Stephen Barron, et al.
Vaccine|December 4, 2012
New technologies and procedures for cervical cancer screeningJack Cuzick, Christine Bergeron, Magnus von Knebel Doeberitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2008
Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smearsAnne Szarewski, Laurence Ambroisine, Louise Cadman, et al.
BJU International|November 6, 2007
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and gradingDaniel M Berney, Gabrielle Fisher, Michael W Kattan, et al.
Breast Cancer Research : BCR|September 30, 2020
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 yearsAdam R Brentnall, Ruth Warren, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|April 29, 2015
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trialPatricia A Mote, Anne Gompel, Chris Howe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention TrialsJack Cuzick, Adam R Brentnall, Corrinne Segal, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
Urologic Oncology|April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillanceDaniel W Lin, E David Crawford, Thomas Keane, et al.
Pageof 37